Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT

Background: The treatment of people with diabetes with metformin can reduce cardiovascular disease (CVD) and may reduce the risk of cancer. However, it is unknown whether or not metformin can reduce the risk of these outcomes in people with elevated blood glucose levels below the threshold for diabe...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Simon J Griffin, M Angelyn Bethel, Rury R Holman, Kamlesh Khunti, Nicholas Wareham, Gwen Brierley, Melanie Davies, Andrew Dymond, Rose Eichenberger, Philip Evans, Alastair Gray, Colin Greaves, Kyla Harrington, Graham Hitman, Greg Irving, Sarah Lessels, Ann Millward, John R Petrie, Martin Rutter, Mike Sampson, Naveed Sattar, Stephen Sharp
التنسيق: Artigo
اللغة:Inglês
منشور في: NIHR Journals Library 2018-04-01
سلاسل:Health Technology Assessment
الموضوعات:
prevention
cardiovascular risk
cardiovascular disease
metformin
diabetes
type 2 diabetes
impaired glucose tolerance
hyperglycaemia
الوصول للمادة أونلاين:https://doi.org/10.3310/hta22180
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة